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Abstract
Background: The vast majority of dynamometer-based animal models for investigation of the response to chronic
muscle contraction exposure has been limited to analysis of isometric, lengthening, or shortening contractions
in isolation. An exception to this has been the utilization of a rat model to study stretch-shortening contractions
(SSCs), a sequence of consecutive isometric, lengthening, and shortening contractions common during daily activity
and resistance-type exercise. However, the availability of diverse genetic strains of rats is limited. Therefore, the
purpose of the present study was to develop a dynamometer-based SSC training protocol to induce increased
muscle mass and performance in plantarflexor muscles of mice.
Methods: Young (3 months old) C57BL/6 mice were subjected to 1 month of plantarflexion SSC training. Hindlimb
muscles were analyzed for muscle mass, quantitative morphology, myogenesis/myopathy relevant gene expression,
and fiber type distribution.
Results: The main aim of the research was achieved when training induced a 2-fold increase in plantarflexion peak
torque output and a 19% increase in muscle mass for the agonist plantaris (PLT) muscle. In establishing this model,
several outcomes emerged which raised the value of the model past that of being a mere recapitulation of the rat
model. An increase in the number of muscle fibers per transverse muscle section accounted for the PLT muscle
mass gain while the antagonist tibialis anterior (TA) muscle atrophied by 30% with preferential atrophy of type IIb
and IIx fibers. These alterations were accompanied by distinct gene expression profiles.
Conclusions: The findings confirm the development of a stretch-shortening contraction training model for the
PLT muscle of mice and demonstrate that increased cross-sectional fiber number can occur following high-intensity
SSC training. Furthermore, the TA muscle atrophy provides direct evidence for the concept of muscle imbalance in
phasic non-weight bearing muscles, a concept largely characterized based on clinical observation of patients. The
susceptibility to this imbalance is demonstrated to be selective for the type IIb and IIx muscle fiber types. Overall,
the study highlights the importance of considering muscle fiber number modulation and the effect of training on
surrounding muscles in exercise comprised of SSCs.
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Background
Exercise has been recognized as among the most effect-
ive interventions including nutrition at promoting well-
being and alleviating chronic disease [1–4]. As reported
in a review of meta-analyses, exercise, in particular, is as
effective as drug treatment for the prevention of heart
disease and diabetes, the treatment of heart failure, and
the rehabilitation from stroke [5]. Resistance exercise, in
particular, is being considered and/or encouraged to ad-
dress muscle atrophy associated with such conditions such
as cachexia, aging, and type 2 diabetes [1, 2]. Specifically,
resistance exercise promotes adaptation in terms of
greater muscular strength/power and muscle hypertrophy
[2]. Such hypertrophy can come in the form of increased
muscle fiber size and, in some cases, increased muscle
fiber number [2, 6–11].
Daily activity and exercise (including resistance exer-
cise) typically consist of movements requiring a se-
quence of different types of contractions, isometric,
lengthening, and shortening contractions, i.e. SSCs [12].
To investigate the response to contractions with high
control and precision, dynamometer based animal stud-
ies have been utilized [13]. The majority of these studies
have investigated isometric, lengthening, or shortening
contractions in isolation in order to characterize the
impact of each contraction mode alone [13, 14]. An ex-
ception to this has been the study of SSCs in their entir-
ety in a rat model [13, 15–17]. However, this animal
model has been limited in regard to diversity of genetic-
ally defined strains available.
Mice are the most commonly used animal model for
biomedical research. This is largely because they have
biological similarities to humans, have been character-
ized as experimental models for nearly a century, and
are available in thousands of genetically defined strains
to aid in the investigation of molecular mechanisms (e.g.
more than 7,000 genetically defined strains are main-
tained at Jackson Laboratories) [18]. Given these advan-
tages, establishment of a SSC training protocol for mice
would provide a valuable research tool for determining
the molecular mechanisms of muscle adaptation.
The aim of the present study was to develop a
dynamometer-based SSC training protocol to induce
adaptation of muscle mass and performance gains for
plantarflexor muscles of mice. We hypothesized that
the plantarflexor muscles of mice would adapt to one
month of training with sessions of 80 SSCs, a protocol
based on that which has been demonstrated previously
to be effective for hindlimb muscles of rats [15, 16, 19].
Consistent with the hypothesis, the 80 SSC protocol in-
duced an increase in plantarflexion performance and
PLT muscle mass. Additionally, unanticipated outcomes
emerged which raised the value of the training model
further. Following SSC training, the performance increase
and agonist muscle mass gain was accompanied by an
increase in muscle fiber number in transverse muscle
sections while the antagonist muscle, the TA muscle,
atrophied. These outcomes were not observed in previous
research regarding the rat model [13, 15–17]. Further-
more, we characterized fiber type transitions and utilized
the Myogenesis & Myopathy RT2 Profiler™ PCR Array to
establish gene expression profiles for these plantarflexion
SSC training induced alterations. The outcomes of this
research establish this SSC training mouse model as an
exceptional research model and provides insights into




A total of 18 male C57BL/6 J mice (Jax# 000664) at
3 months of age were obtained and housed in an Associ-
ation for Assessment and Accreditation of Laboratory
Animal Care (AAALAC)-accredited animal quarters. All
animal procedures were approved by the Animal Care and
Use Committee at the National Institute for Occupational
Safety and Health in Morgantown, WV.
Plantarflexion SSC training
Plantarflexor muscles were exposed to SSC training
based on a previously validated procedure which in-
duced muscle mass and performance gains in young rats
[15, 16, 19]. For each SSC session, the mouse was anes-
thetized with isoflurane gas and placed in dorsal recum-
bency on a heated table. The particular anesthesia was
selected because isoflurane does not have an observable
effect on in vivo muscle force output [20]. The left foot
was secured to a footplate of a dual mode muscle lever
system (Whole Mouse Test System, 1300A, Aurora
Scientific) allowing measurement of torque and control
of foot rotation about the ankle. Platinum electrodes
were placed subcutaneously to activate the tibial nerve
for stimulation of the plantarflexor muscles. For all of
the contractions, muscle stimulation was set at parame-
ters for maximal contraction; 8-V magnitude, 0.2-ms
pulse duration, and 150-Hz frequency.
Both static and dynamic performance was assessed
prior to exposure to the 80 SSC session. Static perform-
ance was assessed by exposing the muscles to a single
maximal isometric tetanic contraction for 200 ms with
the ankle at 90° (angle between tibia and foot). After a
2-min rest, dynamic performance was assessed by ex-
posure to a single SSC test consisting of an isometric
contraction for 200 ms at an ankle angle of 110°, then
rotating the ankle to 70° at 500° per second, then
returning to 110° at 500° per second, and lastly con-
tinuing activation for an additional 200 ms. Peak force
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was determined by assessing the maximum force dur-
ing the stretch phase.
The 80 SSC session was administered 2 min following
the single SSC test. The protocol consisted of 8 sets of
SSCs (2-min intervals between sets) and 10 SSCs per set
(3-s intervals between SSCs) with the interval durations
chosen so as to be comparable to those typically sug-
gested for resistance exercise training [21]. For each
SSC, while the muscles were maximally activated, the
ankle was set to 90° for 100 ms, rotated to 70° at 60°/s,
returned to 90° at 60°/s, and deactivated 100 ms later.
Such a velocity of 60°/s promotes hypertrophy without
overt muscle inflammation and degeneration in young
rats in the days to weeks following chronic SSC expos-
ure [15, 19, 22]. Following the 80 SSCs, a single maximal
isometric tetanic contraction was measured at 5 min
and a single SSC test was assessed at 7 min using the
same parameters as those for these measures prior to
the 80 SSC exposure. Comparison of these post- with
pre-80 SSC exposure values provided a means to deter-
mine extent of recovery from fatigue [16]. Training con-
sisted of 4 weeks of 2 to 3 days per week of SSC
sessions. The performance measures for sessions during
the first and last week of the SSC exposures were aver-
aged to determine initial non-trained and final trained
values, respectively. At 72 h after the final SSC exposure,
hindlimb muscles were removed, weighed, and the tibia
length recorded. For trained muscles and contralateral
non-trained muscles, muscle mass was divided by tibia
length to determine normalized muscle mass. The mid-
belly of the muscles were covered with tissue freezing
media (Tissue-Tek, Sakura Finetek) and frozen in cold
isopentane (−80 °C) for quantitative morphology and
immunoflurescence. A portion of the remaining tissue
was allocated for gene expression analysis.
Quantitative morphology
The mid-belly of each muscle was cryosectioned at 12 μm
thickness. The cryosections were hematoxylin and eosin
stained by the following protocol – 100% ethanol for 30 s,
water for 1 min, Harris Hematoxylin for 3 min, water for
30 s, 0.1% acid alcohol for 30 s, water for 90 s, 80%
ethanol for 30 s, Eosin Y for 1 min, 100% ethanol for
150 s, and Xylene for several dips. The sections were then
analyzed by quantitative morphology using a standardized
stereological method [17, 23, 24]. The investigator was
blinded to sample identification during this analysis.
The stereological method entailed identifying two non-
overlapping regions to the right and left of the section
midline. At each of these regions, stereological analysis
was performed at 5 equally spaced sites across the muscle
section. At each site, points of a 121-point 11-line overlay
graticule (0.04 mm2 square with 100 divisions) were evalu-
ated at 40× magnification [17]. Each point was identified
as overlaying a muscle fiber (degenerative or non-
degenerative) or interstitium (cellular or non-cellular).
Degenerative muscle fibers were considered to have all of
the following attributes: loss of contact with surrounding
fibers, interdigitation of the sarcolemma by cellular infil-
trates, and internalization of cellular infiltrates as apparent
in the hematoxylin/eosin stained muscle sections [23]. If a
muscle fiber lacked these characteristics, the fiber was
considered to be non-degenerative. Cellular interstitium
were counted when points overlaid nuclei in between
muscle fibers. Points that overlaid interstitial regions
without nuclei were counted as non-cellular interstitium.
Percent of muscle tissue comprised of non-degenerative
muscle fibers, degenerative muscle fibers, centrally nucle-
ated muscle fibers, cellular interstitium, or non-cellular
interstium were calculated as the percentage of points
which overlaid each type of tissue relative to the total
number of points. The number of muscle fibers were also
counted when the topmost point of the fiber perimeter
was within the boundary of the graticule and this was di-
vided by the total area sampled to determine number of
muscle fibers per unit cross-sectional area. Mean muscle
fiber area (μm2) was determined by dividing the percent
of tissue comprised of muscle fibers by fiber number per
unit area.
Gene expression analysis
Muscle tissue which was flash frozen and stored at
−80 °C was retrieved and a ~20 mg portion was ho-
mogenized with a Minin-BeadBeater 8 (Biospec) while
in a vial containing 1 ml of TRIzol and 1.0 mm zirconia
beads (BioSpec, Cat#11079110zx). RNA was isolated
using the RNAqueous Phenol-free total RNA Isolation
Kit (Ambion, Cat# AM1912). cDNA was synthesized
using the RT2 First Strand Kit (Qiagen, Cat# 330401).
Samples were then analyzed using the Mouse Skeletal
Muscle: Myogenesis & Myopathy RT2 Profiler™ PCR
Array (Qiagen, Cat# PAMM-099Z) and RT2 SYBR
Green Mastermix (Qiagen, Cat# 330523) per manufac-
turer’s instructions with use of an Applied Biosystems
7500 Real-Time PCR instrument. Fold changes and P
values were determined from Ct values analyzed using
the analysis template provided by Qiagen (PCRArray-
Dataanalysis_V4). Criteria for gene expression exceed-
ing 1.3-fold change and P < 0.05 were used to identify
differentially expressed genes. Bioinformatic analysis
was performed for differentially expressed genes using
Ingenuity Pathway Analysis (IPA; Ingenuity Systems,
www.ingenuity.com). IPA biological functions with the
exception of cancer specific functions were evaluated.
Fiber type analysis
The transversely cryosectioned mid-belly of each muscle
underwent immunofluorescence myosin heavy chain
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(MHC) staining using a previously described method
[16]. Sections were blocked with 10% goat serum in
PBS for one hour at room temperature and then incu-
bated in the following primary antibody cocktail over-
night at 4 °C – antibodies against MHC I (BA-F8; 1:10),
MHC IIa (SC-71; 1:200), MHC IIb (BF-F3;1:200), and
laminin (L9393;1:400). MHC antibodies were purchased
from Developmental Studies Hybridoma Bank (University
of Iowa) and the laminin antibody was purchased from
Sigma. A cocktail of secondary Alexa Fluor antibodies
(Life Technologies) were applied for two hours at room
temperature – 350 IgG2b goat anti mouse (A21140;
1:250), 594 IgG1 goat anti-mouse (A21125; 1:100), 488
IgM goat anti-mouse (A21042; 1:500), and 488 IgG goat
anti-rabbit (A11008; 1:500).
Fiber type analysis was performed by a standardized
stereological method [15, 16]. With the investigator
blinded to sample identification, stereological analysis
was systematically repeated at 5 equally spaced sites
across the section on each side of the midpoint. At each
site, points of a 121-point 11-line overlay graticule
(0.04 mm2 square with 100 divisions) were evaluated at
20× magnification. Since 121 points were evaluated in
10 fields, a total of 1210 points were analyzed per
muscle section. Each point was identified as overlaying a
MHC I (blue), MHC IIa (red), MHC IIb (green), MHC
IIx (lacking staining), and interstitium. The number of
muscle fibers corresponding to each fiber type were also
counted when the topmost point of the fiber perimeter
was within the boundary of the graticule. The total num-
ber of fibers counted divided by the total area sampled
over the 10 regions (i.e. 0.4 mm2) was calculated to de-
termine the number of fibers per unit cross-sectional
area (number of fibers per mm2). The percentage of each
fiber type was determined by dividing the number of fi-
bers corresponding with each fiber type by the total
number of fibers counted. Mean muscle fiber area (μm2)
for a particular fiber type was determined by dividing
the percent of tissue comprised of that fiber type by the
appropriate fiber number per unit area.
Statistical analysis
Data were analyzed using paired Student’s t-tests or
ANOVA (JMP version 11, SAS Institute, Inc., Cary, NC)
with the variable of animal identification as a random
factor to account for repeated measures when appropri-
ate. Post hoc comparisons were performed using
Fisher’s least significant difference method. When nor-
mality could not be assumed, data were analyzed with
the Wilcoxon Signed Rank Test. Chi-square analysis
(SigmaPlot version 12.5, Systat Software, Inc., San Jose,
CA) was utilized to determine training-induced differ-
ences in the absolute frequency distributions of fiber
type. All data are expressed as means ± SE. P < 0.05 was
considered statistically significant.
Results
Effective SSC training for enhancement in plantarflexion
performance accompanied by differential responses in
muscle mass PLT and TA muscles
Plantarflexion SSC training increased static performance
two-fold in terms of maximum isometric torque and
dynamic performance in terms of peak torque during
the SSC test (Fig. 1a and b). This increase in plantarflex-
ion performance was accompanied by a 19% increase in
PLT muscle mass and a 30% decrease in TA muscle
mass with no change in mouse body weight, 25.6 ± 0.6 g
in the initial non-trained state and 25.3 ± 0.6 g after
training (Fig. 2a). Training had no effect on gastrocne-
mius and soleus muscle mass. Normalized muscle
masses for trained gastrocnemius and soleus muscles,
7.16 ± 0.18 and 0.48 ± 0.04 mg/mm, respectively, were
Fig. 1 Plantarflexion SSC training enhanced plantarflexor muscle
performance. Values of a static performance in terms of maximum
isometric torque and b dynamic performance in terms of peak
torque during a single SSC test were assessed. Sample sizes were
N = 9 per group. Values are means ± SE. *Different from non-trained
value, P < 0.05
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not different from values for contralateral muscles, 7.38
± 0.15 and 0.44 ± 0.05 mg/mm. Investigation at the
muscle fiber level revealed distinct training induced al-
terations accounting for the changes in muscle mass for
the PLT and TA muscles. The number of muscle fibers
per transverse muscle section increased for PLT muscles
while no effect of training was observed for TA muscles
(Fig. 2b). The mean muscle fiber area decreased for TA
muscles with no such effect for PLT muscles (Fig. 2c).
Therefore, the results indicated that the increased
muscle mass for PLT muscles was due to the addition of
muscle fibers in cross-section while the decreased
muscle mass for TA muscles was due to muscle fiber
atrophy.
Hematoxylin and eosin stained muscle sections were
then evaluated for extent of overt degeneration in
muscle fibers and presence of cellular constituents in
the interstitium (Fig. 3). For both muscles, no signifi-
cant extent of muscle fiber degeneration was observed,
a finding consistent with the absence of an overt in-
flammatory response (Table 1). The muscles differed in
the extent of training-induced alterations in the inter-
stitium and prevalence of centrally nucleated fibers.
For PLT muscles, the effects of training were limited
to the interstitium in that the percentage of tissue
composed of non-cellular interstitium and cellular
interstitium increased (Table 1). However, these in-
creases were marginal considering that the percentage
Fig. 2 The agonist PLT muscle increased muscle mass with plantarflexion SSC training whereas the antagonist TA muscle atrophied. Values for a
muscle mass (normalized by tibia length) b number of muscle fibers per transverse muscle section, and c mean muscle fiber area were determined.
For PLT muscles, an increase in the number of muscle fibers in cross-section accompanied the increase in mass. For TA muscles, atrophy was observed
at the individual muscle fiber level. N = 9 per group with exception of total muscle fiber counts for PLT muscles. A subpopulation of all the PLT muscle
sections (N = 3 to 8 per group) fulfilled the requirement for direct fiber counts – the requirement that all regions of the muscle section be free
of technical defects typically incurred from prepping and cryosectioning such a relatively small muscle. Other measures (e.g. muscle fiber area)
were obtained from all of the PLT muscle sections (N = 9 per group) because these relied on the sampling approach of stereological quantitative
morphology. Values are means ± SE. *Different from non-trained value, P < 0.05
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of tissue consisting of muscle fibers was unaltered.
This was not the case for TA muscles. For these mus-
cles, the training-induced increases in the composition
of non-cellular interstitium and cellular interstitium
were sufficiently increased enough to account for a
decrease in percentage of tissue composed of muscle
fibers. In addition, an increase in percentage of cen-
trally nucleated fibers was observed (Table 1 and
Fig. 3).
Gene expression analysis indicating muscle specific
regulation of myogenesis, atrophy/hypertrophy, energy
metabolism, and skeletal muscle fiber type
To investigate the differential responses in PLT and TA
muscles further, gene expression of 84 genes was ana-
lyzed using the Mouse Skeletal Muscle: Myogenesis &
Myopathy RT2 Profiler™ PCR Array. For PLT muscles,
24 genes were differentially expressed, grouped based on
gene function according to the PCR array manufacturer’s
recommendations, and analyzed by IPA to determine
highly predicted biological functions (Additional file 1:
Tables S1, Additional file 2: Table S2, Additional file 3:
Table S3, Additional file 4: Table S4 and Additional file 5
Table S5). Hypertrophy was the most predicted function
to be upregulated. The prediction in IPA was largely
based on the transcriptional response in autocrine/
hypertrophy signaling genes (e.g. Mstn), and the down-
regulation of genes which can promote atrophy (e.g.
Fbxo32, Foxo1, and Hdac5). Consistent with muscle
hypertrophy as a consequence of increased fiber number
in cross-section, the fusion of cells and quantity of
muscle cells were among the highest predicted biological
functions. IPA attributed enhanced fusion of cells to the
upregulation of Tgfb1, Myf5, Myog, and Igf2 and down-
regulation of Foxo1 while the prediction of increased
muscle cell quantity was attributed to the upregulation
of Myog and Pax7 and downregulation of Foxo1 and
Mstn. In regards to energy metabolism, IPA predicted a
training induced shift away from glycolysis based on the
downregulation of Hk2, Slc2a4, Pdk4 and upregulation
Fig. 3 Altered muscle fiber morphology was most noticeable in TA muscle sections following plantarflexion SSC training especially in terms of an
increased proportion of centrally nucleated muscle fibers. Transverse sections of PLT and TA muscles were stained with hematoxylin and eosin.
Scale bar = 100 μm
Table 1 Quantitative morphology for muscles of mice exposed




Non-degenerative muscle fibers (%) 86.7 ± 0.9 84.5 ± 0.5
Degenerative muscle fibers (%) 0.0 ± 0.0 0.0 ± 0.0
Non-cellular interstitium (%) 12.2 ± 0.7 14.3 ± 0.5*
Cellular interstitium (%) 0.8 ± 0.1 1.3 ± 0.1*
Centrally nucleated fibers (%) 4.0 ± 0.9 14.0 ± 5.2
TA
Non-degenerative muscle fibers (%) 88.2 ± 0.5 83.2 ± 1.4*
Degenerative muscle fibers (%) 0.0 ± 0.0 0.0 ± 0.0
Non-cellular interstitium (%) 11.1 ± 0.5 15.2 ± 1.3*
Cellular interstitium (%) 0.7 ± 0.1 1.6 ± 0.2*
Centrally nucleated fibers (%) 1.5 ± 0.7 17.5 ± 5.7*
Sample sizes were N = 9 per group. Percentage refers to percentage of tissue.
Values are means ± SE. *Different from non-trained muscle, P < 0.05
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of Myog. Consistent with this, was the indication of an
alteration in fiber type distribution with the downregula-
tion of Tnni2, Tnnt3, and upregulation of Myh1.
A total of 27 genes were differentially expressed for
TA muscles following plantarflexion SSC training
(Additional file 1: Tables S1, Additional file 2: Table
S2, Additional file 3: Table S3 and Additional file 4:
Table S4). Cell death was among the most highly pre-
dicted to be increased by IPA (Additional file 5: Table S5).
In IPA, this prediction was attributed largely to upregula-
tion of Casp3 and Lmna and downregulation in Rps6kb1,
Pax3, and genes for proteins relevant to dystroglycan and
titin (Dag1, Ttn, Capn3, and Camk2g). The downregula-
tion of genes for dystroglycan and titin complex-related
proteins also resulted in the prediction of decreased skel-
etal muscle function.
Atrophy of muscle was another highly predicted func-
tion largely based on the upregulation of Casp3 and
downregulation in Ppargc1a and Ttn. Apoptosis appeared
relevant considering the prediction for the category of
apoptosis of neurons based on upregulation of Casp3 and
Musk and the downregulation of Pargc1a and Fgf2.
Several predicted functions (e.g. glucose metabolism dis-
order, hyperglycemia, and transport of D-glucose) sug-
gested the development of a metabolic disorder for TA
muscles consistent with the downregulation of Ppargc1a,
Rps6kb1, Slc2a4, and Prkab2. The downregulation of
Tnni2, Tnnt3, and Myh2 suggested training-induced fiber
type transitions also occurred for TA muscles. Overall,
the gene expression analysis indicated plantarflexion
SSC training-induced shifts in fiber type distribution
along with opposing outcomes in terms of hyper-
trophy/atrophy, muscle function, and metabolism for
PLT and TA muscles.
Improved energy metabolism for PLT muscles confirmed
by enhanced fatigue recovery
To determine whether the gene expression in PLT mus-
cles regarding energy metabolism was consistent with
muscle performance, functional data was evaluated further
in terms of plantarflexion fatigue and recovery from fa-
tigue. Fatigue was investigated during the first set of con-
tractions in each SSC session. Training increased absolute
peak torque values for all of the contractions of the first
set (Fig. 4a). When these torque values were normalized
to the first contraction of the session, only a marginal
training-induced difference was observed for the final five
contractions of the set (Fig. 4b). Therefore, the plantar-
flexor muscles adapted so that the rate of fatigue remained
largely unchanged despite an increased metabolic demand
concomitant with greater torque production.
Recovery from fatigue was evaluated for both the iso-
metric contraction and the single SSC test contraction
several minutes following each SSC session. Training
improved the extent to which both of these measures
returned to pre-session values (Fig. 4c and d). A training-
induced change was observed for individual post-session
isometric torque traces (Fig. 4e). Traces for non-trained
muscles exhibited a 31% decrease in torque during the
contraction while trained muscles had only a 15% decline
(Fig. 4 f). The implication was that training improved
fatigue recovery as evident by the maximum torque values
for post-session contractions and by an improved ability
to maintain torque within these contractions.
Differential response in fiber type distribution and size
for PLT and TA muscles
Fiber type analysis was performed to investigate a poten-
tial mechanism for enhanced fatigue recovery in PLT
muscles (Fig. 5). For PLT muscles, a shift from type IIb
to type IIx muscle fibers was observed (Fig. 6a). Consist-
ent with muscle fiber size data determined from analyz-
ing hematoxylin and eosin stained sections (Fig. 2c),
there were no training-induced changes in fiber area
with the exception of an increase observed for type I
fibers, fibers which make up only a marginal percentage
of all fibers in PLT muscles (Fig. 6b). Therefore, overall,
muscle fibers of PLT muscles shifted to a more oxidative
phenotype without muscle fiber atrophy, a finding con-
sistent with improved fatigue recovery capability in the
context of muscle adaptation.
The muscle fiber type results for TA muscles were
distinct from those for PLT muscles. Training induced a
decrease in percentage of type IIb fibers accompanied by
increases in the percentage of both type IIx and IIa
fibers (Fig. 6a). This response was concomitant with
decreases in muscle fiber size for both type IIb and IIx
fibers. Such decreased size in the most prevalent muscle
fiber types, IIb and IIx fibers, without an effect on type
IIa fiber size demonstrated the selective nature of the
atrophy in TA muscles induced by plantarflexion SSC
training.
Discussion
In the present study, we developed a novel adaptive SSC
protocol for plantarflexor PLT muscles of mice, thereby
effectively addressing the aim and hypothesis of the
study in establishing in mice a practical and influential
model for the study of SSC training. In developing this
model, two major findings were observed. First, a shift
in fiber type distribution accompanied by increased total
fiber number (rather than enlarged fiber size) in cross-
section as responsible for the increase in PLT muscle
mass. This result highlights the present study as provid-
ing a unique model of SSC-induced adaptation given
that our previous research regarding SSC training in rats
demonstrated the more typical response of muscle fiber
hypertrophy concomitant with increased muscle mass
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Fig. 4 (See legend on next page.)
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[19]. The second major finding of the study was the 30%
decrease in the antagonist TA muscle mass with select-
ive atrophy of type IIb and IIx fibers. Such an induced
muscle imbalance indicates the profound detrimental
effects of limiting resistance-type training to specific
muscles without regard to surrounding muscles. Overall,
the results have impact on understanding SSC-induced
adaptation in regards to implementation in the mouse
model, fiber type transitions, fiber number modulation,
and the induction of muscle imbalance.
In developing this SSC training for the induction of
increased plantarflexion torque and muscle mass, the
serendipitous consequence of a shift to a more oxidative
metabolism was evident by analysis of fatigue recovery,
gene expression, and fiber type data. Increased max-
imum isometric force recovery has been observed previ-
ously for muscles of rats exposed to contraction-induced
training [16, 25, 26]. In this study, we demonstrate that
not only did fatigue recovery improve in terms of max-
imum isometric force but also capacity to maintain force
generation during the entirety of a contraction shortly
following a SSC session improved with training. Interest-
ingly, resistance to fatigue during the first set of SSCs
was largely unaltered with training. A comparable result
of a shift away from type IIb fibers and differential adap-
tation for enhanced fatigue recovery rather than fatigue
resistance has been observed for SSC-trained rats and
endurance trained human subjects [16, 27]. This sup-
ports the concept that recovery from fatigue, rather than
the susceptibility to fatigue, presents as more sensitive to
certain training-induced alterations in fiber type [16, 27].
The training-induced alteration in metabolism for PLT
muscles was apparent at the transcriptional level. A shift
away from glycolysis was evident by the downregulation
of genes for Slc2a4 (Glut4; glucose transporter), Hk2
(prepares glucose for glycolysis), and AMPK (a regulator
of Glut4 and Hk2 expression) [28–30]. The upregulation
of Myog may underlie this metabolic alteration. Myog
overexpression in mice induces a shift from glycolytic to
oxidative metabolism [31, 32]. At the fiber type level, the
(See figure on previous page.)
Fig. 4 Plantarflexion SSC training improved plantarflexion recovery from fatigue. Values for peak torque were evaluated for the first set of 10
contractions. a With training, absolute values improved for all contractions of the first set. b When peak torques were normalized to that of the
first contraction, training had no effect early in the set followed by a marginal effect late in the set. To assess recovery from fatigue, c an isometric
contraction and d a single SSC test were assessed 5 minutes and 7 minutes after a training session of 80 SSCs, respectively. These values were
expressed relative to their pre-session values. e For the isometric contraction following a session of 80 SSCs, maximum torque production typically
could not be completely maintained for the duration of the contraction. However, a training-induced improvement in the degree to which torque
could be maintained was noticed by reference to raw torque traces. f The extent to which torque was maintained during a post-session isometric
contraction was quantified by expressing the torque at the termination of muscle activation as a percentage of the maximum torque value at the
onset of contraction. Sample sizes were N = 9 per group. Values are means ± SE. *Different from non-trained value, P < 0.05
Fig. 5 Differential fiber type distribution and size outcomes following plantarflexion SSC training for PLT and TA muscles. Laminin (green) and
multiple MHC isoforms – I (blue), IIa (red), IIb (green) and IIx (negative for staining) – were identified by immunofluorescence. For PLT muscles, a
shift from IIb to IIx fibers was apparent with no overt type II fiber size changes. For TA muscles, a shift from type IIb to IIx and IIa fibers accompanied
by decreases in fiber sizes especially for type IIb and IIx fibers were noticeable. Scale bar = 50 μm
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metabolic alteration of the present study is further sup-
ported with the shift from type IIb to IIx fibers and the
upregulation of Myh1, coding for MHC IIx.
The observation of increased fiber number per PLT
muscle cross-section was a novel finding in an animal
model of SSC training. For the SSC training model in
rats, increased muscle fiber size can account for the in-
duced muscle hypertrophy [19]. With training, mean
fiber size for rats of that study increased by 14% (2867 ±
107 vs. 2521 ± 84 μm, trained vs non-trained, P = 0.01)
while fiber number did not (16,227 ± 529 vs. 15,966 ±
646 fibers, trained vs. non-trained, P = 0.65) [19]. This
differential outcome may be due to differences in the
mechanical strain of the SSC training protocols in terms
of the extent muscles stretched and shortened each con-
traction. For the protocol utilized previously, muscles
were stretched and shortened through an ankle rotation
of 50° [15–17, 19]. Because of limitations in the muscle
lever system of the present study, the ankle rotated
through a decreased excursion (20° of ankle rotation).
Consequently, muscles were exposed to SSCs which
were more moderate when compared with those of previ-
ous studies. The finding that only PLT muscles increased
in muscle mass while the other plantarflexor muscle
masses were unaltered is consistent with the moderate na-
ture of the training. Based on the glycolytic fiber type
characteristics of the PLT muscle relative to the other
plantarflexor muscles (soleus and gastrocnemius), the PLT
Fig. 6 Quantification of fiber type distribution and size for PLT and TA muscles. a Frequency distributions for fiber type are presented as percentage of
total number of fibers counted for each group (N = 9 muscles per group). Chi-square analysis was performed to determine alterations in distribution
with training. b Mean muscle fiber size for each fiber type. Values are means ± SE. *Different from non-trained value, P < 0.05
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muscle is recruited less often during daily activity and,
consequently, activation during SSC training would be
especially novel and sensitive to adaptation [33].
Evidence for contraction-induced increases in muscle
fiber number has been observed in several studies regard-
ing voluntary resistance training in animal models and hu-
man subjects [6–11]. The present study demonstrates that
such a response can occur after high-intensity SSC
training consisting of maximal activation of muscles.
This increased fiber number potentially could have
been mediated by the downregulation of Mstn. Postnatal
muscle-specific inactivation of Mstn results in increased
cross-sectional fiber number accounting for ~30% of the
increase in whole muscle section area [34]. Furthermore, a
missense mutation in Mstn causes increased muscle fiber
number without fiber hypertrophy [35]. Consistent with
the downregulation of Mstn in the present study, Igf2 was
upregulated. Myostatin is a negative regulator of Igf2 ex-
pression [36]. Despite the common belief that Igf2 has
only a marginal role during postnatal muscle growth, re-
cent studies have indicated otherwise [36, 37]. Pigs with a
SNP within intron 3 of the paternal Igf2 allele have in-
creased postnatal Igf2 expression and greater muscle mass
[37, 38]. High postnatal levels of Igf2 also accompany the
increased muscle mass of Mstn null mice [36]. In addition
to gene expression consistent with increased fiber number,
the gene expression analysis was indicative of enhanced
muscle fiber survival as evident by the downregulation
of genes involved in protein degradation. Several genes
associated with Fbxo32 (Atrogin-1) induced protein
degradation (via the ubiquitin-proteasome pathway)
were downregulated - Fbxo32, Foxo1, Myod1, and
Hdac5 [39, 40]. Capn3, the gene encoding the calpain 3
protease involved in an alternative proteolytic pathway,
was also downregulated [40].
Whether the fiber number increase of the present
study represents a completely different form of adapta-
tion than that observed in the SSC trained rat model or
characterizes an earlier stage of adaptation remains un-
known. For instance, SSC training may induce first a
fiber number increase, as observed in the present study,
and then fusion of fibers (e.g. fusion of myofibers or
branched fibers) with a return to control value fiber
numbers, as observed in previous research regarding the
rat SSC model [15–17, 19, 41]. This order of adaptation
has been proposed as a possibility by others during re-
generation following muscle injury [41, 42]. The present
study is distinctive in suggesting that such a sequence of
adaptation may also occur for muscles exposed to non-
injurious training.
The concept of muscle imbalance has been character-
ized as hypertrophy or high recruitment of one muscle
or muscle group as linked to an atrophy response in op-
posing muscles [43, 44]. Muscle imbalance has been
implicated in underlying such conditions as lumbopel-
vic instability, lower back pain, susceptibility to knee in-
jury, and shoulder pathology [43, 45, 46]. Based on
observations of patients, phasic muscles (rather than
tonic postural muscles) have been considered suscep-
tible to possible atrophy and weakness from muscle im-
balance [44]. Our findings regarding the phasic non-
weight bearing TA muscles provide direct evidence for
this concept. Furthermore, the present study establishes
a gene expression profile and fiber type phenotype for
muscle imbalance. The severity of the TA muscle atro-
phy was apparent at the gene expression level as
evident by the downregulation for genes encoding
proteins associated with titin and dystroglycan, proteins
essential for force transmission during contractions
[47]. Such downregulation suggested that the muscle
was compromised in terms of quality (decreased ex-
pression of genes for cytoskeletal/sarcomeric proteins
per unit of muscle mass) as well as quantity (i.e. overall
muscle mass decrement). The depreciated state of the
TA muscle was also evident by the upregulation of
Cryab, an opposite change of regulation to that of the
PLT muscle. Cryab encodes αB chain crystallin (i.e.
heat shock protein B5), a molecular chaperone that
binds misfolded proteins to prevent the accumulation
of protein aggregates and is upregulated in stress/
pathological conditions [48]. Gene expression analysis
indicates that such a compromised condition in TA
muscles was accompanied by the upregulation of gene
expression promoting muscle atrophy (e.g. Casp3) and
downregulation of genes which repress such atrophy
(e.g. Pax3 and Rps6kb1) [49, 50]. The downregulation
of Rps6kb1 was especially noteworthy given that
Rps6kb1 encodes p70 Ribosomal protein S6 kinase 1, a
protein intimately linked to protein synthesis via regu-
lation of major components of translation - Ribosomal
S6 protein, eukaryotic translation initiation factor 4B,
and eukaryotic elongation factor 2 [50, 51]. This indi-
cated that the gene expression profile was consistent
with decreased protein synthesis in addition to en-
hanced atrophy.
A neuromuscular imbalance may underlie the atrophy
response for the TA muscle [44]. One instance of an
onset of such an imbalance is when antagonist muscle
activity is reduced secondary to training-induced ten-
sion of the agonist [52, 53]. This response contributes
to the increased force production in trained agonist
muscles. However, if antagonistic muscle inhibition is
pervasive enough to be prevalent (even during daily activ-
ity between training sessions) such a response could be
detrimental to antagonistic muscles. The notion of de-
creased antagonist activity is supported by the gene ex-
pression of Myog and Musk. Muscle-specific receptor
tyrosine kinase (Musk) signals clustering of acetylcholine
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receptors and muscle activity suppresses expression out-
side of the neuromuscular junction [54]. When activity is
abolished by denervation, myogenin upregulates Musk in
an embryonic pre-innervation pattern of gene expression
[54]. In the present study, Myog and Musk were highly
upregulated (9- and 2-fold increases, respectively), a
finding consistent with diminished TA muscle activity.
Preliminary research regarding dorsiflexion SSC training
also supports the notion that decreased muscle activity
may underlie the antagonistic atrophy of the present
study.. Following dorsiflexion SSC training of young
(3 month old) Sprague Dawley rats (N = 4), TA muscles,
which are agonists in this case, increase normalized
muscle mass by the expected 20% (trained vs non-trained;
17.3 ± 0.6 vs 14.4 ± 0.7 mg/mm; P = 0.03). Interestingly, for
the same animals, such training had no effect on antagon-
ist muscle masses in this situation, the tonic weight-
bearing plantarflexor muscles (trained vs non-trained; PLT
– 8.3 ± 0.2 vs 8.3 ± 0.2 mg/mm; gastrocnemius - 39.3 ± 1.2
vs 39.6 ± 1.3 mg/mm; and soleus - 3.3 ± 0.2 vs 3.4 ± 0.1).
When these results are considered along with the present
study, phasic non-weight bearing phasic TA muscle may
be largely inhibited without significant impact on daily ac-
tivity as in the present study while plantarflexor muscles
may be protected from severe inhibition because of their
weight-bearing activity in the preliminary study.
The shift away from MHC IIb observed for TA mus-
cles in the present study is consistent with several re-
ports regarding the MHC distribution alteration
observed for fast-twitch muscles (e.g. TA and laryngeal
muscles) following immobilization, nerve transection,
and toxin-induced muscle paralysis [55–58]. Although
the distribution alteration away from MHC IIb is in
common with that of the PLT muscles, the downregula-
tion of Ppargc1a suggests a diminished metabolic cap-
acity for TA muscles after plantarflexion SSC training.
Ppargc1a encodes peroxisome proliferator-activated re-
ceptor gamma coactivator-1α (PGC-1α), a master regula-
tor of mitochondrial biogenesis and oxidative enzymes
[59]. The downregulation of Ppargc1a coupled with a shift
from MHC IIb fibers to MHC IIx and MHC IIa fibers
suggests metabolic changes without the typical MHC
alteration. A disconnect between MHC composition and
metabolic capacity has already been shown to be possible
previously for transgenic mice which overexpress myo-
genin [31]. The transition away from type IIb fibers in the
present study was accompanied by atrophy of IIb and IIx
fibers while type IIa fiber size was preserved. This ten-
dency for a greater propensity for type IIb/x to atrophy
has also been observed following immobilization of TA
muscles, a finding consistent with specific catabolic condi-
tions [60, 61]. Therefore, the atrophy of TA muscles in the
present study was a function of both a shift in fiber type
distribution (from large IIb fibers to smaller IIx and IIa
fibers) and atrophy within fiber type, specifically for type
IIb and IIx fibers.
The plantarflexion SSC training induced 30% atrophy
of the TA muscle is striking given that this occurred at a
young age, an age with high adaptive capacity and resist-
ance to maladaptation as evident in resistance training
for human subjects [62, 63]. Likewise in a previous re-
port, when muscles of young rats were directly exposed
to a severe SSC protocol – a protocol which induced
performance deficits at maturity and old age – the re-
sponse was muscle hypertrophy and enhanced perform-
ance [16]. However, these past studies were limited in
that only agonist muscles were evaluated. The present
study demonstrates that antagonist muscles are more
susceptible to such maladaptation following a distinct
SSC protocol; and, therefore, supports the concept of
investigating antagonist and surrounding muscles in
addition to the agonist muscle when evaluating training
regimes. Such investigation is especially warranted be-
cause muscle imbalance can be largely subclinical until
severe joint mobility, maladaptation, or possibly injury
manifests. General activity/training alone is not suffi-
cient to prevent this maladaptation as evident by studies
demonstrating that elite athletes incur muscle imbalance
[43, 46].
Overall, the outcomes of the present investigation ef-
fectively address the rational and aim of the study – to
develop a dynamometer-based SSC training protocol to
induce muscle mass and performance gains for the
plantarflexor PLT muscle of mice. Regarding the major
finding of increased muscle fiber number per PLT
cross-section, a limitation was not being able to deter-
mine the precise mechanism (i.e. muscle fiber splitting
vs de novo fiber formation) with the available data. Des-
pite this, the finding establishes that increased fiber
number is a possible response to high-intensity SSC
training and warrants further investigation. The other
major finding of the study - plantarflexion SSC training
induced muscle imbalance in the antagonist TA muscle of
mice - provides the scientific community with a novel
model to investigate muscle imbalance. In addition, the
finding is consistent with the proposal that antagonist
phasic muscles are susceptible to imbalance when agonist
muscles are exposed to contractions in isolation [43, 44].
Fortunately, such training-induced muscle imbalance is
not inevitable. Research regarding volitional weight-lifting
for rats demonstrates that squat-like training induces
hypertrophy in the agonist plantarflexor muscles without
atrophy of the antagonist TA muscle, a muscle activated
for stabilization during squats [64]. Resistance-type train-
ing requiring antagonist stabilization should be considered
as a potential strategy to prevent the occurrence of muscle
imbalance. The further development of concepts for exer-
cise prescription are justified to ensure the prevention of
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such deleterious outcomes as those observed for the
phasic antagonist muscle of the present study.
Conclusions
In summary, the present study establishes a dynamometer-
based SSC training protocol to induce gains in perform-
ance and PLT muscle mass for mice, an underrepresented
animal model for the study of SSC-induced adaptation.
The major finding of a SSC-induced increase in cross-
sectional muscle fiber number rather than muscle fiber size
provides an impetus for the scientific community to re-
think the pervasiveness of muscle fiber hypertrophy vs
fiber number modulation following resistance-type train-
ing. A greater understanding of fiber number modulation
has potential clinical relevance in countering conditions as-
sociated with muscle fiber loss such as aging, muscular
dystrophy, and accident-related denervation. The other
major finding of the study (i.e. the observation of SSC-
induced muscle imbalance in the antagonist TA muscle of
mice) confirms the notion that imbalance to phasic mus-
cles can result from exposure of agonist muscle to repeated
sessions of contractions. The clinical implication is to
utilize exercises which require activation of antagonist
muscles for stabilization as a strategy to prevent the onset
of muscle imbalance during physical therapy.
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